Cristina Rodriguez-Antona

13PUBLICATIONS
120CO-AUTHORS
Molecular targetsPharmacogenomicsPredictive and prognostic markersEpidemiological modellingGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 29, 2025
Treatment Efficacy and Molecular Dynamics of Neoadjuvant Durvalumab and Olaparib in Resectable Urothelial Bladder Cancer: The NEODURVARIB Trial.

Juan F Rodríguez-Moreno, Guillermo de Velasco, Carlos Álvarez-Fernández

|Aug 13, 2024
PharmVar GeneFocus: CYP4F2.

Pablo Zubiaur, Cristina Rodríguez-Antona, Erin C Boone

|Mar 05, 2024
Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease.

Dhanya Ramachandran, Jonathan P Tyrer, Stefan Kommoss

|Jun 01, 2023
Deubiquitinase USP9X loss sensitizes renal cancer cells to mTOR inhibition.

Juan M Roldán-Romero, Carlos Valdivia, Maria Santos

|Jul 26, 2022
Single-nucleotide polymorphism associations with efficacy and toxicity in metastatic castration-resistant prostate cancer treated with cabazitaxel.

Daniel Herrero Rivera, Carmen Garrigós Vacas, Laura Marcos Kovandzic

|Feb 19, 2022
Clinical pharmacogenetic analysis in 5,001 individuals with diagnostic Exome Sequencing data.

Javier Lanillos, Marta Carcajona, Paolo Maietta

Pageof 3

Frequent Collaborators

3 joint publications

Susan J Ramus

3 joint publications

Iain A McNeish

3 joint publications

Jenny Chang-Claude

3 joint publications

Anna deFazio